SEC Form 4 · accession 0001225208-19-005112
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendy Carruthers
Officer — SVP, Human Resources
Period of report
Mar 11, 2019
Accepted (ET)
Mar 12, 2019 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2019 | M | 29,412 | $7.47 | A | 200,751 | D | |
| Common StockF2 | Mar 11, 2019 | S | 29,412 | $39.6327 | D | 171,339 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.47 | Mar 11, 2019 | M | 29,412 | D | Mar 7, 2015 | Mar 7, 2021 | Common Stock | 29,412 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.52 to $39.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in whole on March 7, 2015, the fourth anniversary of the grant.